These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16527616)
21. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia. Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497 [TBL] [Abstract][Full Text] [Related]
22. A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript. Li X; Yang J; Chen X; Liu J; Li H; Zheng J; He Y; Chen Z; Huang S Cancer Genet Cytogenet; 2007 Jul; 176(2):166-8. PubMed ID: 17656262 [TBL] [Abstract][Full Text] [Related]
23. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript. Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251 [TBL] [Abstract][Full Text] [Related]
24. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia. Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients. Jha CB; Kucheria K; Choudhary VP Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893 [TBL] [Abstract][Full Text] [Related]
26. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477 [TBL] [Abstract][Full Text] [Related]
27. A dual colour dual fusion fluorescence in situ hybridisation study on the genesis of complex variant translocations in chronic myelogenous leukaemia. So CC; Wan TS; Yip SF; Chan LC Oncol Rep; 2008 May; 19(5):1181-4. PubMed ID: 18425374 [TBL] [Abstract][Full Text] [Related]
28. High incidence of derivative chromosome arm 9q deletions in Asian chronic myelogenous leukemia. Tien SL; Rudduck-Sivaswaren C; Lim P; Lim E; Lie DK; Tan PH; Lee AS Genes Chromosomes Cancer; 2005 Apr; 42(4):433-4. PubMed ID: 15645497 [No Abstract] [Full Text] [Related]
29. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia. Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309 [TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651 [TBL] [Abstract][Full Text] [Related]
31. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis. Radojkovic M; Ristic S; Pavlovic S; Colovic M Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous occurrence of t(9;22)(q34;q11.2) and t(16;16)(p13;q22) in a patient with chronic myeloid leukemia in blastic phase. Zámecníkova A; Al Bahar S; Ramesh P Cancer Genet Cytogenet; 2008 Jun; 183(2):109-13. PubMed ID: 18503829 [TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone. Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540 [TBL] [Abstract][Full Text] [Related]
34. Two case reports of 1q triplication in myeloproliferative neoplasms. Park TS; Lee SG; Cheong JW; Song J; Lee KA; Kim J; Yoon S; Choi JR Cancer Genet Cytogenet; 2009 Jun; 191(2):111-2. PubMed ID: 19446749 [No Abstract] [Full Text] [Related]
35. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment. Rowe LR; Brothman AR; Nibley WE; Gaffney MR; Chen Z Cancer Genet Cytogenet; 2007 Apr; 174(1):54-6. PubMed ID: 17350467 [TBL] [Abstract][Full Text] [Related]
37. Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia. Wu J; Huang L; Huang M; Liu W; Zheng M; Cao Y; Liu Y; Zhang Y; Lu Y; Xu G; Wang S; Ma D; Zhou J Exp Hematol; 2009 Jan; 37(1):87-91. PubMed ID: 18951692 [TBL] [Abstract][Full Text] [Related]
38. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML. Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799 [No Abstract] [Full Text] [Related]
39. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia. Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279 [TBL] [Abstract][Full Text] [Related]